Author

Mingge Song

China Pharmaceutical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Dawei WangiD· 1 shared Fei HuangiD· 1 shared Haiping HaoiD· 1 shared Jiayu DingiD· 1 shared Jinxin Jiang· 1 shared Kai YuaniD· 1 shared Liping WangiD· 1 shared Minghui Ji· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Dawei WangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting protein tyrosine phosphatase non-receptor type 2 with a novel inhibitor for AML therapy

Wenbin Kuang, Jinxin Jiang, Xiao Wang, Dawei Wang, Minghui Ji, Yasheng Zhu, Kai Yuan, Jiayu Ding, Wenmu Wang, Mingge Song, Wenjian Min, Fei Huang, Liping Wang, Wanjian Gu, Haiping Hao, , Peng Yang

This study identifies PTPN2 as a therapeutic target in AML, discovers a selective inhibitor K73, and demonstrates its efficacy in reducing AML burden in vitro and in vivo.

bioRxiv · May 7, 2024 · PreprintCancer Biology